MedTrace Logo

Effective Withdrawal Time and Adenoma Detection Rate

NCT06063720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2025-09-10

No results posted yet for this study

Summary

This study prospectively evaluated the role of EWT versus SWT on adenoma detection rate (ADR) and other key quality metrics. In this prospective single-center study, patients undergoing colonoscopy were enrolled. EWT was calculated in real-time using an AI system with endoscopists blinded to the results. We performed multivariable analyses to assess the association of EWT and SWT with binary (e.g., ADR) and count outcomes (e.g., adenoma per colonoscopy \[APC\]), after adjusting for patient and procedural characteristics.

Conditions

  • Colonic Polyp
  • Colon Adenoma
  • Artificial Intelligence

Interventions

DEVICE

Endoscreen QC

Artificial intelligence monitoring of effective withdrawal time

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Ka Luen Thomas Lui · The University of Hong Kong

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-09-30
Completion
2025-01-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06063720 on ClinicalTrials.gov